1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pet Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Infectious Diseases
        1.2.3 Dermatological Diseases
        1.2.4 Orthopedic Diseases
        1.2.5 Behavioral Disorders
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Pet Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Dogs
        1.3.3 Cats
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Pet Therapeutics Market Perspective (2017-2028)
    2.2 Pet Therapeutics Growth Trends by Region
        2.2.1 Pet Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Pet Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Pet Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Pet Therapeutics Market Dynamics
        2.3.1 Pet Therapeutics Industry Trends
        2.3.2 Pet Therapeutics Market Drivers
        2.3.3 Pet Therapeutics Market Challenges
        2.3.4 Pet Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pet Therapeutics Players by Revenue
        3.1.1 Global Top Pet Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Pet Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Pet Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pet Therapeutics Revenue
    3.4 Global Pet Therapeutics Market Concentration Ratio
        3.4.1 Global Pet Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pet Therapeutics Revenue in 2021
    3.5 Pet Therapeutics Key Players Head office and Area Served
    3.6 Key Players Pet Therapeutics Product Solution and Service
    3.7 Date of Enter into Pet Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Therapeutics Breakdown Data by Type
    4.1 Global Pet Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Pet Therapeutics Forecasted Market Size by Type (2023-2028)
5 Pet Therapeutics Breakdown Data by Application
    5.1 Global Pet Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Pet Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Pet Therapeutics Market Size (2017-2028)
    6.2 North America Pet Therapeutics Market Size by Country (2017-2022)
    6.3 North America Pet Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Pet Therapeutics Market Size (2017-2028)
    7.2 Europe Pet Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Pet Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pet Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Pet Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Pet Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Pet Therapeutics Market Size (2017-2028)
    9.2 Latin America Pet Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Pet Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pet Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Pet Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Pet Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Elanco
        11.1.1 Elanco Company Detail
        11.1.2 Elanco Business Overview
        11.1.3 Elanco Pet Therapeutics Introduction
        11.1.4 Elanco Revenue in Pet Therapeutics Business (2017-2022)
        11.1.5 Elanco Recent Development
    11.2 Boehringer Ingelheim GmbH
        11.2.1 Boehringer Ingelheim GmbH Company Detail
        11.2.2 Boehringer Ingelheim GmbH Business Overview
        11.2.3 Boehringer Ingelheim GmbH Pet Therapeutics Introduction
        11.2.4 Boehringer Ingelheim GmbH Revenue in Pet Therapeutics Business (2017-2022)
        11.2.5 Boehringer Ingelheim GmbH Recent Development
    11.3 Ceva Sante Animale
        11.3.1 Ceva Sante Animale Company Detail
        11.3.2 Ceva Sante Animale Business Overview
        11.3.3 Ceva Sante Animale Pet Therapeutics Introduction
        11.3.4 Ceva Sante Animale Revenue in Pet Therapeutics Business (2017-2022)
        11.3.5 Ceva Sante Animale Recent Development
    11.4 Dechra Pharmaceuticals
        11.4.1 Dechra Pharmaceuticals Company Detail
        11.4.2 Dechra Pharmaceuticals Business Overview
        11.4.3 Dechra Pharmaceuticals Pet Therapeutics Introduction
        11.4.4 Dechra Pharmaceuticals Revenue in Pet Therapeutics Business (2017-2022)
        11.4.5 Dechra Pharmaceuticals Recent Development
    11.5 Eli Lilly and Company
        11.5.1 Eli Lilly and Company Company Detail
        11.5.2 Eli Lilly and Company Business Overview
        11.5.3 Eli Lilly and Company Pet Therapeutics Introduction
        11.5.4 Eli Lilly and Company Revenue in Pet Therapeutics Business (2017-2022)
        11.5.5 Eli Lilly and Company Recent Development
    11.6 Merck
        11.6.1 Merck Company Detail
        11.6.2 Merck Business Overview
        11.6.3 Merck Pet Therapeutics Introduction
        11.6.4 Merck Revenue in Pet Therapeutics Business (2017-2022)
        11.6.5 Merck Recent Development
    11.7 Vetoquinol
        11.7.1 Vetoquinol Company Detail
        11.7.2 Vetoquinol Business Overview
        11.7.3 Vetoquinol Pet Therapeutics Introduction
        11.7.4 Vetoquinol Revenue in Pet Therapeutics Business (2017-2022)
        11.7.5 Vetoquinol Recent Development
    11.8 Zoetis
        11.8.1 Zoetis Company Detail
        11.8.2 Zoetis Business Overview
        11.8.3 Zoetis Pet Therapeutics Introduction
        11.8.4 Zoetis Revenue in Pet Therapeutics Business (2017-2022)
        11.8.5 Zoetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global Pet Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Infectious Diseases
    Table 3. Key Players of Dermatological Diseases
    Table 4. Key Players of Orthopedic Diseases
    Table 5. Key Players of Behavioral Disorders
    Table 6. Key Players of Others
    Table 7. Global Pet Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Pet Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Pet Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Pet Therapeutics Market Share by Region (2017-2022)
    Table 11. Global Pet Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Pet Therapeutics Market Share by Region (2023-2028)
    Table 13. Pet Therapeutics Market Trends
    Table 14. Pet Therapeutics Market Drivers
    Table 15. Pet Therapeutics Market Challenges
    Table 16. Pet Therapeutics Market Restraints
    Table 17. Global Pet Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Pet Therapeutics Market Share by Players (2017-2022)
    Table 19. Global Top Pet Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Therapeutics as of 2021)
    Table 20. Ranking of Global Top Pet Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Pet Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Pet Therapeutics Product Solution and Service
    Table 24. Date of Enter into Pet Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Pet Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Pet Therapeutics Revenue Market Share by Type (2017-2022)
    Table 28. Global Pet Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Pet Therapeutics Revenue Market Share by Type (2023-2028)
    Table 30. Global Pet Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Pet Therapeutics Revenue Market Share by Application (2017-2022)
    Table 32. Global Pet Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Pet Therapeutics Revenue Market Share by Application (2023-2028)
    Table 34. North America Pet Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Pet Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Pet Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Pet Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Pet Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Pet Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Pet Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Pet Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Pet Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Pet Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Elanco Company Detail
    Table 45. Elanco Business Overview
    Table 46. Elanco Pet Therapeutics Product
    Table 47. Elanco Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
    Table 48. Elanco Recent Development
    Table 49. Boehringer Ingelheim GmbH Company Detail
    Table 50. Boehringer Ingelheim GmbH Business Overview
    Table 51. Boehringer Ingelheim GmbH Pet Therapeutics Product
    Table 52. Boehringer Ingelheim GmbH Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
    Table 53. Boehringer Ingelheim GmbH Recent Development
    Table 54. Ceva Sante Animale Company Detail
    Table 55. Ceva Sante Animale Business Overview
    Table 56. Ceva Sante Animale Pet Therapeutics Product
    Table 57. Ceva Sante Animale Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
    Table 58. Ceva Sante Animale Recent Development
    Table 59. Dechra Pharmaceuticals Company Detail
    Table 60. Dechra Pharmaceuticals Business Overview
    Table 61. Dechra Pharmaceuticals Pet Therapeutics Product
    Table 62. Dechra Pharmaceuticals Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
    Table 63. Dechra Pharmaceuticals Recent Development
    Table 64. Eli Lilly and Company Company Detail
    Table 65. Eli Lilly and Company Business Overview
    Table 66. Eli Lilly and Company Pet Therapeutics Product
    Table 67. Eli Lilly and Company Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
    Table 68. Eli Lilly and Company Recent Development
    Table 69. Merck Company Detail
    Table 70. Merck Business Overview
    Table 71. Merck Pet Therapeutics Product
    Table 72. Merck Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
    Table 73. Merck Recent Development
    Table 74. Vetoquinol Company Detail
    Table 75. Vetoquinol Business Overview
    Table 76. Vetoquinol Pet Therapeutics Product
    Table 77. Vetoquinol Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
    Table 78. Vetoquinol Recent Development
    Table 79. Zoetis Company Detail
    Table 80. Zoetis Business Overview
    Table 81. Zoetis Pet Therapeutics Product
    Table 82. Zoetis Revenue in Pet Therapeutics Business (2017-2022) & (US$ Million)
    Table 83. Zoetis Recent Development
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pet Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Infectious Diseases Features
    Figure 3. Dermatological Diseases Features
    Figure 4. Orthopedic Diseases Features
    Figure 5. Behavioral Disorders Features
    Figure 6. Others Features
    Figure 7. Global Pet Therapeutics Market Share by Application in 2021 & 2028
    Figure 8. Dogs Case Studies
    Figure 9. Cats Case Studies
    Figure 10. Other Case Studies
    Figure 11. Pet Therapeutics Report Years Considered
    Figure 12. Global Pet Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Pet Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Pet Therapeutics Market Share by Region: 2021 VS 2028
    Figure 15. Global Pet Therapeutics Market Share by Players in 2021
    Figure 16. Global Top Pet Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Therapeutics as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Pet Therapeutics Revenue in 2021
    Figure 18. North America Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Pet Therapeutics Market Share by Country (2017-2028)
    Figure 20. United States Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Pet Therapeutics Market Share by Country (2017-2028)
    Figure 24. Germany Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Pet Therapeutics Market Share by Region (2017-2028)
    Figure 32. China Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Pet Therapeutics Market Share by Country (2017-2028)
    Figure 40. Mexico Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Pet Therapeutics Market Share by Country (2017-2028)
    Figure 44. Turkey Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Pet Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Elanco Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
    Figure 47. Boehringer Ingelheim GmbH Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
    Figure 48. Ceva Sante Animale Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
    Figure 49. Dechra Pharmaceuticals Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
    Figure 50. Eli Lilly and Company Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
    Figure 51. Merck Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
    Figure 52. Vetoquinol Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
    Figure 53. Zoetis Revenue Growth Rate in Pet Therapeutics Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed